Trademarkia Logo

Canada

C$
ASCENDIS
REGISTERED

on 6 Sept 2019

Last Applicant/ Owned by

ASCENDIS PHARMA A/S

Tuborg Boulevard 5 2900 Hellerup

DK

Serial Number

1824725 filed on 27th Feb 2017

Registration Number

TMA1053020 registered on 6th Sept 2019

Registration expiry Date

6th Sept 2029

Correspondent Address

SMART & BIGGAR LP

SUITE 1000, 55 METCALFE STREETP.O. BOX 2999, STATION DOTTAWA

ONTARIO

CA

K1P5Y6

ASCENDIS

Trademark usage description

pharmaceutical and veterinary preparations for the treatment of physical and mental illness, namely, pharmaceutical preparations for the treatment of Read More

Classification Information


Class [005]
Pharmaceutical and veterinary preparations for the treatment of physical and mental illness, namely, pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely, growth and thyroid disorders, growth hormone deficiency, hypoparathyroidism, achondroplasia, diabetes, fibroblast growth factor receptor(FGFR)-related skeletal disorders, oncology, ophthalmology, infectious diseases and disorders namely, Intestinal infectious diseases, Infections with a predominantly sexual mode of transmission, Viral infections of the central nervous system, Arthropod-borne viral fevers and viral haemorrhagic fevers, Viral infections characterized by skin and mucous membrane lesions, Human immunodeficiency virus [HIV] disease, Mycoses, Protozoal diseases, Helminthiases, enzyme replacement therapy for the treatment of lysosomal storage diseases, anti-inflammatory disease, pain, namely, for the relief of pain and for the treatment of chronic pain, respiratory system disorder, autoimmune disorders, vaccines for human and veterinary use , non-alcoholic steatohepatitis, psychiatric and other brain diseases and disorders, namely, anxiety, mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, multiple sclerosis, bone diseases, CNS diseases, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, myopathies, namely, muscular diseases caused by structural and functional abnormalities of skeletal muscle tissue, namely muscular dystrophies, congenital muscular dystrophies, congenital myopathies, distal myopathies, other myopathies namely, myofibrillar, incusion body, myotonic syndromes, ion channel muscle diseases, malignant hyoperthermias, metabolic myopathies, congenital myasthenic syndromes, sarcopenia, muscle atrophy and cachexia and metabolic diseases of muscle, metabolic myopathies, mintochondria myopathies namely, muscular dystrophy, mucopolysaccharideoses, and cancer, obesity, wound healing, the hormonal system, namely growth hormone deficiency, diabetes and angiogenesis, the ophthalmological system, namely angiogenesis, the angiogenic system, the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, the immune system, namely, immunologic diseases, namely, autoimmune diseases and immunologic deficiency syndromes, the cardio-vascular system, the metabolic system, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, the respiratory system, the musculo-skeletal system, namely, growth hormone deficiency, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, the genitourinary system, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of inflammatory disorders, namely, anti-inflammatories; pharmaceutical preparations for use in dermatology, namely, dermatitis, eczema, psoriasis, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; sanitary preparations for medical purposes, namely, sanitizing wipes, disinfectants for medical instruments, adhesive tapes for medical purposes, dietetic foods, namely, dietetic sugar substitutes adapted for medical use, all-purpose disinfectants for sanitary purposes; fungicides, herbicides


Classification kind code

11

Class [042]
Scientific research within the medical, pharmaceutical and bacteriological area; providing scientific consultancy and information in the fields of pharmaceuticals, vaccines and medicines and bacteriology; testing of pharmaceuticals; packaging design, designing and development of medical equipment; developing pharmaceutical and medical preparations; design and development of pharmaceutical formulations; design and development of granulation technology and tablet technology; providing scientific consultancy and information relating to the design and development of granulation technology and tablet technology


Classification kind code

11

Class [045]
Licensing of industrial property, legal services


Classification kind code

11

Mark Details


Serial Number

1824725

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 190
on 17th Jul 2019
Registration Pending
Submitted for opposition 42
on 24th Apr 2019
Advertised
Submitted for opposition 26
on 4th Apr 2019
Approved
Submitted for opposition 27
on 11th Feb 2019
Approval Notice Sent
Submitted for opposition 15
on 20th Aug 2018
Correspondence Created
Submitted for opposition 22
on 7th Mar 2018
Search Recorded
Submitted for opposition 20
on 7th Mar 2018
Examiner's First Report
Submitted for opposition 31
on 1st Mar 2017
Formalized
Submitted for opposition 1
on 28th Feb 2017
Created
Submitted for opposition 30
on 27th Feb 2017
Filed